Daniel S. Goldman sold Enanta Pharmaceuticals Inc (NASDAQ: ENTA)
Daniel S. Goldman (D-NY), a U.S. Representative, has disclosed 1 trade in Enanta Pharmaceuticals Inc (ENTA) since 2023, a single sale, worth an estimated $8K in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Daniel S. Goldman sold $1,001 - $15,000 of Enanta Pharmaceuticals Inc (NASDAQ: ENTA) on July 12, 2023. Since that trade, ENTA is down -33.54% against the S&P 500 up +72.17%, an outperformance of -105.71%.
Data updated
Daniel S. Goldman's ENTA trades vs the price
ENTA is down -33.54% since Daniel S. Goldman sold on July 12, 2023, versus +72.17% for the S&P 500.
Performance since this trade
All Daniel S. Goldman ENTA trades
Daniel S. Goldman & ENTA trading FAQ
Is it legal for Daniel S. Goldman to trade Enanta Pharmaceuticals Inc (ENTA) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Enanta Pharmaceuticals Inc (ENTA), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Daniel S. Goldman sell ENTA?
Daniel S. Goldman disclosed a sale of $1,001 - $15,000 of Enanta Pharmaceuticals Inc (ENTA) on July 12, 2023, according to public STOCK Act filings.
How has ENTA performed since Daniel S. Goldman's trade?
Since Daniel S. Goldman sold ENTA on July 12, 2023, the stock is down -33.54%, versus +72.17% for the S&P 500 over the same period, an outperformance of -105.71%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional ENTA trades?
Quantellect tracks every disclosed congressional trade in Enanta Pharmaceuticals Inc (ENTA) on the Enanta Pharmaceuticals Inc congressional trading page, which aggregates filings across all members of Congress.
Daniel S. Goldman's ENTA tradesAll congressional filings for Enanta Pharmaceuticals IncDaniel S. Goldman's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.